You are using an older browser version. Please use a supported version for the best MSN experience.

Divi’s Labs shares jump over 6% after USFDA completes inspection

LiveMint logoLiveMint 20-09-2017 Livemint

New Delhi: Divi’s Laboratories Ltd on Wednesday said the US Food and Drug Administration (USFDA) has completed its inspection at the company’s Visakhapatnam plant.

At 11.07am, Divi’s Labs shares were trading 6.23% higher at Rs917.70, while the benchmark Sensex index was up 27 points, or 0.08%, at 32,429.

The USFDA inspected the company’s Unit-2 at Vizag from 11-19 September to verify the corrective actions proposed previously by the US agency, Divi’s Labs said in a BSE filing. The company said “all previous observations have been confirmed as completed and resolved”.

The company added that the USFDA issued a Form 483, citing six procedural observations. Divi’s Labs said it will respond to the observations within the stipulated time.

More From LiveMint

image beaconimage beaconimage beacon